📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways
The White House moved to accelerate federal handling of psychedelic drugs, including ibogaine, while leaving core approval, scheduling and reimbursement hurdles in place. President Donald Trump on April 18 signed an e...
Can an LLM get high? 5 Questions with clinical neuroscientist Ziv Ben-Zion
Ben-Zion discusses how artificial intelligence mimics the psychedelic experience.
5 Things We Learned at Psychedelic Culture 2026
Plus, ketamine addiction, DMT lasers, and plant medicine faeries [...] Read More... The post 5 Things We Learned at Psychedelic Culture 2026 appeared first on DoubleBlind Mag.
Global Altered States: The Storefront Psychedelic
This week’s Sunday Insider: inside a storefront where Psychedelics are no longer a journey…they’re a choice.
Psychonautisme, Herbes et Suppléments
De nombreux aliments et compléments alimentaires courants contiennent des composés actifs qui interagissent avec la neurochimie de notre corps, et cela devient particulièrement pertinent lorsqu’ils sont associés à des...
MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy
April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements from Co-Executive Directors Betty Aldworth and Ismail L. Ali, J.D., on today’s Executive Order regardin...
Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols
What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West and Fletcher Burdick argue that safety, lineage, context, and individualized care cannot be separate...
Evaluating the Pros and Cons of State Psychedelic Task Forces
While state legislatures across the U.S. are creating task forces to evaluate proposed legislation to regulate psychedelic-assisted therapies, there remains a disconnect between what advocates want and what legislato...
Scientists test if ketamine has antidepressant effects under anesthesia; France is the first to approve IV ketamine for severe suicidal crisis
Plus: New research on the role of trip sitters; Various state bills move to expand psychedelics research and access
The Life You Call “Normal” Was Designed
Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.
Wait, Are We In a Simulation?
This DMT laser experiment suggests yes, but neuroscientists say probably not. [...] Read More... The post Wait, Are We In a Simulation? appeared first on DoubleBlind Mag.
A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter
Dear Colleagues,We write as a collective of practitioners, researchers, clinicians, and integration specialists with direct, long-term experience working with iboga and ibogaine across a range of settings. The growing...
Dr. Michael Alpert and Peter Alberding – ALS, Existential Distress, and Ketamine Therapy
Dr. Michael Alpert and Peter Alberding discuss ALS, ketamine-assisted psychotherapy, end-of-life fear, music, trust, and how one patient used ketamine to face mortality with more clarity and less fear. The post Dr. Mi...
Psychedelics in the Age of Eco-Anxiety
Eco-anxiety is a rising response to environmental crises that can be transformed into resilience and action through support, connection, and therapeutic psychedelic experiences. The post Psychedelics in the Age of Eco...
Where Does the World Go to Dance? Probs These EDM Festivals
A global guide to the festivals worth planning for. [...] Read More... The post Where Does the World Go to Dance? Probs These EDM Festivals appeared first on DoubleBlind Mag.